BACKGROUND AND AIM: The identification of reliable biomarkers for severe Coronavirus
Disease 2019 (COVID-19) is still needed. Therefore, we analyzed mannose-binding lectin …

Background/Aim: The lung-specific soluble lectins, SP-A and SP-D have been clinically
used to diagnose interstitial lung disease, but their clinical significance in COVID-19 remains …

OBJECTIVE: Mannose-binding lectin (MBL) is one of the important parts of the complement
system. In our study, we aimed to determine serum MBL levels and their relationship with …

Abstract Background Coronavirus disease 2019 (COVID-19) was announced in early
December 2019. The pandemic situation is declared. This study aimed to evaluate the role …

Mannose-binding lectin (MBL) binds to SARS-CoV-2, inhibits infection of susceptible cells,
and activates the complement system via the lectin pathway. In this study, we investigated …

Although some evidence showed the activation of complement systems in COVID-19
patients, proinflammatory status and lectin pathway remain unclear. Thus, the present study …

Introduction Mannose-binding lectin (MBL) promotes opsonization, favoring phagocytosis
and activation of the complement system in response to different microorganisms, and may …

Abstract ground: A cytokine storm is defined by elevated levels of proinflammatory cytokines
such as interleukin-6 (IL-6). In COVID-19 infection, IL-6 is superior to C-reactive protein …

Abstract Objectives Sars-CoV-2 acute infection is clinically heterogeneous, ranging from
asymptomatic cases to patients with a severe, systemic clinical course. Among the involved …

Background To investigate the prognostic value of a novel immune-inflammatory index, the
interleukin-6-to-lymphocyte ratio (IL-6/LY), with the clinical outcomes of severe coronavirus …